covid 19 News and Research

RSS

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Scientists evaluated the incidence and severity of breakthrough SARS-CoV-2 infections among individuals with immune-mediated inflammatory diseases undergoing B cell depleting therapy.

25 Feb 2022

Research could pave the way for adoption of precision medicine approaches for COVID-19

The COVID-19 pandemic has revealed a frightening reality; the course of infection with this disease is highly variable. Some young patients have died from the virus, whereas several elderly people have survived without experiencing respiratory symptoms at all. Researchers are left wondering: why?

25 Feb 2022

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

Researchers examined systemic B and T cell responses 16 weeks after BNT162b2 vaccination, and the potency of vaccine-induce neutralizing antibodies, in hemodialysis patients and healthcare workers with no comorbidities.

25 Feb 2022

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Researchers characterized humoral and SARS-CoV-2 S-specific T cell responses in IBD patients who received two-dose mRNA-based COVID-19 vaccination series.

25 Feb 2022

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Researchers evaluated CMIR in IBD patients following immunization with two doses of COVID-19 vaccine.

25 Feb 2022

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

In a review published in the International Journal of Molecular Sciences, researchers have been reviewing the use of siRNAs to target coronaviruses.

25 Feb 2022

COVID babies score slightly lower on developmental screening test

In this interview, we speak to Dr. Dani Dumitriu about her latest research that investigated the development screening test scores for babies born during COVID-19.

25 Feb 2022

Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

In a recent peer-reviewed study, posted to the journal Geoscience Frontiers, researchers conducted a systematic meta-analysis on several studies that assessed the viral RNA load of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in effluents, sludge, and biosolids, and found that the prevalence of SARS-CoV-2 RNA is highest in sludge, followed by biosolids and effluent respectively.

25 Feb 2022

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Scientists from the Case Western Reserve University, USA, have recently conducted a study in collaboration with the National Institutes of Health, USA, to investigate the incidence rates and disease severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States before and after the emergence of omicron variant.

24 Feb 2022

Interleukin-1 Receptor-Like 2 cytokine accomplishes a dual effect in inflammation and healing

The Interleukin-1 Receptor-Like 2 (IL-1RL2) cytokine can promote inflammatory diseases and have a role in controlling infection.

24 Feb 2022

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Researchers assess the serological response to a real-world COVID-19 vaccination strategy in older individuals who resided in long-term care facilities.

24 Feb 2022

MAIT cells exercise complex functions and may be targets for future immunotherapies and vaccines

A Stony Brook University physician-scientist has identified that mucosal-associated invariant T (MAIT) cells, an unconventional form of immune cell, exercise several complex roles during healthy and disease states.

24 Feb 2022

Should SARS-CoV-2 Omicron be considered a serotype?

A recent article provides evidence for and against the hypothesis of SARS-CoV-2 serotypes.

24 Feb 2022

Vaccinated adults were less likely to land in intensive care during the omicron surge

The highly contagious omicron variant of SARS-CoV-2 became the dominant strain in the United States in mid-December 2021, coinciding with a rise in hospitalizations of patients with COVID-19.

24 Feb 2022

COVID-19's impact on the hopes and dreams of Australians

Researchers investigate the effect of COVID-19 on the hopes and dreams of Australians.

24 Feb 2022

A comparison of COVID-19 vaccines by neutralizing antibody potency

Researchers use an international standardized assessment method to compare the efficacy of antibody responses to the major COVID-19 vaccines.

24 Feb 2022

Melatonin as a safe and potentially life-saving treatment for COVID-19

A new study discusses the possible role of melatonin, an antioxidant and anti-inflammatory agent, in treating COVID-19.

24 Feb 2022

Researchers analyze the use of palliative care for hospitalized patients with both AKI and COVID-19

Acute kidney injury (AKI) is a common complication of COVID-19 and is associated with a higher risk of death. A new study published in CJASN has examined the use of palliative care in patients with COVID-19 and AKI.

24 Feb 2022

COVID-19–related discrimination more prevalent among racial and ethnic minority groups in the U.S.

People from all major racial and ethnic minority population groups in the United States report experiencing more COVID-19-related discrimination than white adults, a new study shows.

24 Feb 2022

Scientists reveal the possibility to improve immunological memory in vaccines

A key transcription factor in T-cell immunology is crucial to the immune system's "memory" in recognizing threats it has already faced before – and it may be possible to improve this immunological memory in vaccines, according to a new paper by scientists at the Hackensack Meridian Center for Discovery and Innovation.

24 Feb 2022

covid 19 News and Research

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Research could pave the way for adoption of precision medicine approaches for COVID-19

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

COVID babies score slightly lower on developmental screening test

Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Interleukin-1 Receptor-Like 2 cytokine accomplishes a dual effect in inflammation and healing

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

MAIT cells exercise complex functions and may be targets for future immunotherapies and vaccines

Should SARS-CoV-2 Omicron be considered a serotype?

Vaccinated adults were less likely to land in intensive care during the omicron surge

COVID-19's impact on the hopes and dreams of Australians

A comparison of COVID-19 vaccines by neutralizing antibody potency

Melatonin as a safe and potentially life-saving treatment for COVID-19

Researchers analyze the use of palliative care for hospitalized patients with both AKI and COVID-19

COVID-19–related discrimination more prevalent among racial and ethnic minority groups in the U.S.

Scientists reveal the possibility to improve immunological memory in vaccines

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News